Physician profile
Janet Chou
NPI 1861799496
$1,701.40
in general payments reported to CMS, 2019-2025
18 companies · $621 in 2025
The $621 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $74.86 · 2021: $39.96 · 2022: $169 · 2023: $240 · 2024: $340 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $385.89 | 2019-2025 | Bexsero |
| Sanofi Pasteur INC. | $384.00 | 2019-2025 | |
| Corium, LLC | $190.97 | 2023-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $177.97 | 2019-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Cranial Technologies, INC | $97.13 | 2020-2024 | Doc Band |
| Pfizer INC. | $70.54 | 2019-2024 | |
| Abbott Laboratories | $54.30 | 2025 | Id Now Instrument |
| Seqirus USA INC | $50.84 | 2022-2024 | Flucelvax |
| Vertical Pharmaceuticals, LLC | $48.34 | 2024 | Relexxii |
| Alk-Abello, INC | $45.25 | 2025 | Neffy |
| Sobi, INC | $36.80 | 2019-2023 | |
| Tris Pharma INC | $34.54 | 2019 | |
| Verrica Pharmaceuticals INC. | $32.55 | 2025 | Ycanth |
| Astrazeneca Pharmaceuticals Lp | $24.35 | 2024 | Flumist Quadrivalent |
| Kaleo, INC. | $20.41 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $18.37 | 2022 | |
| Lnhc, INC | $15.24 | 2025 | Zelsuvmi |
| Kowa Pharmaceuticals America, INC. | $13.91 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.